Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 14,300 full-time employees. The company went IPO on 2023-06-16. The firm is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The firm offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The firm manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The firm has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Mr. Anshul Thakrala es el President de Fortrea Holdings Inc, se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción FTRE?
El precio actual de FTRE es de $10.77, ha aumentado un 1.62% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Fortrea Holdings Inc?
Fortrea Holdings Inc pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de Fortrea Holdings Inc?
La capitalización bursátil actual de Fortrea Holdings Inc es $1.0B
¿Es Fortrea Holdings Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 12 analistas han realizado calificaciones de análisis para Fortrea Holdings Inc, incluyendo 1 fuerte compra, 0 compra, 10 mantener, 3 venta, y 1 fuerte venta